Made Tech appoints Hazel Jones as its head of health to continue its rapid growth.
FREMONT, CA: Made Tech, the public sector technology delivery expert, continues its rapid growth with the appointment of the head of health, Hazel Jones. Joining when the NHS has had to quickly embrace digital solutions, Hazel will use her expertise in technology and health to head Made Tech's digital transformation projects across the health service. She will be working to modernize legacy applications and working practices, scale digital service delivery, and enhance client teams' enhanced digital potentials.
Hazel brings with her about 20 years of digital transformation experience across both public and private organizations. Most recently, she headed as Interim Head for NHS Blood & Transplant Rapid Covid Response and Senior Director at Push Doctor, and previously holding the role of Apps & Wearables Programme Director at NHS Digital.
Working for the NHS, Hazel has seen first-hand how Covid-19 has brought hurdles that have led it to embrace digital technologies to still operate and treat patients safely. The pandemic has been vital for the NHS and as it continues to optimize its digital capabilities. She hopes to offer my experience and passion for scaling the health services journey through digital transformation.
Made Tech believes that technology delivery firms working for the public sector should not simply turn up, deploy digital solutions, and then leave. They should help organizations to evolve their workforce skills and digital potentials through co-working. This will make sure that they have the tools and techniques to grow and evolve their digital expertise. Made Tech shares these values to make a difference in the healthcare sector. Hazel brings with her the knowledge, expertise, and passion for healthcare that the company knows will benefit Made Tech and the whole public sector. Her leadership will enable the company to continue supporting the NHS through its digital revolution and help ensure it offers the best solutions possible to the UK, staff, and patients.